Fidelity Disruptive Medicine ETF (NASDAQ:FMED – Get Free Report) saw a large decrease in short interest in July. As of July 31st, there was short interest totaling 325 shares, a decrease of 57.0% from the July 15th total of 756 shares. Based on an average daily trading volume, of 4,595 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company’s stock are short sold.
Fidelity Disruptive Medicine ETF Price Performance
Shares of Fidelity Disruptive Medicine ETF stock traded up $0.15 during midday trading on Monday, hitting $30.36. 1,247 shares of the company were exchanged, compared to its average volume of 11,135. The firm has a market cap of $48.58 million, a P/E ratio of 41.33 and a beta of 0.75. The firm has a 50 day simple moving average of $28.16 and a 200-day simple moving average of $26.25. Fidelity Disruptive Medicine ETF has a 52 week low of $23.48 and a 52 week high of $30.54.
Hedge Funds Weigh In On Fidelity Disruptive Medicine ETF
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in FMED. Virtu Financial LLC bought a new position in Fidelity Disruptive Medicine ETF during the 4th quarter worth approximately $228,000. Jane Street Group LLC grew its holdings in shares of Fidelity Disruptive Medicine ETF by 95.4% in the 4th quarter. Jane Street Group LLC now owns 91,414 shares of the company’s stock valued at $2,473,000 after buying an additional 44,630 shares during the period. Finally, Vise Technologies Inc. bought a new stake in shares of Fidelity Disruptive Medicine ETF in the 4th quarter valued at $234,000.
About Fidelity Disruptive Medicine ETF
The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.
Recommended Stories
- Five stocks we like better than Fidelity Disruptive Medicine ETF
- D-Wave Has Momentum—What Does It Need to Keep It Going?
- TSMC’s Insider Buying Wave Comes With a Bigger AI Question for Investors
- Looking Beyond CrowdStrike? 3 AI Security Stocks Stand Out
- 5 Recession-Proof Stocks Hiding in Cardboard Boxes
Receive News & Ratings for Fidelity Disruptive Medicine ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fidelity Disruptive Medicine ETF and related companies with MarketBeat.com's FREE daily email newsletter.
